Amneal Pharmaceuticals, Inc. (AMRX)
21.38
-0.32
(-1.50%)
USD |
NASDAQ |
Nov 13, 16:00
21.38
0.00 (0.00%)
After-Hours: 19:59
Amneal Pharmaceuticals EPS Diluted (Quarterly) : -0.0646 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0646 |
| June 30, 2026 | 0.1757 |
| March 31, 2026 | 0.1893 |
| December 31, 2025 | 0.1069 |
| September 30, 2025 | 0.0073 |
| June 30, 2025 | 0.0695 |
| March 31, 2025 | 0.0376 |
| December 31, 2024 | -0.1003 |
| September 30, 2024 | -0.0005 |
| June 30, 2024 | 0.0188 |
| March 31, 2024 | -0.2982 |
| December 31, 2023 | -0.4048 |
| September 30, 2023 | 0.0606 |
| June 30, 2023 | 0.0769 |
| March 31, 2023 | -0.0456 |
| December 31, 2022 | -0.0286 |
| September 30, 2022 | -0.0178 |
| June 30, 2022 | -0.8001 |
| March 31, 2022 | -0.0144 |
| December 31, 2021 | -0.0427 |
| September 30, 2021 | -0.0284 |
| June 30, 2021 | 0.0956 |
| March 31, 2021 | 0.0444 |
| December 31, 2020 | -0.0206 |
| September 30, 2020 | -0.0608 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.0814 |
| March 31, 2020 | 0.7777 |
| December 31, 2019 | -0.2184 |
| September 30, 2019 | -2.027 |
| June 30, 2019 | -0.132 |
| March 31, 2019 | -0.375 |
| December 31, 2018 | -0.0689 |
| September 30, 2018 | 0.0542 |
| June 30, 2018 | -0.1503 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -4.18 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -1.375 |
| December 31, 2016 | -3.91 |
| September 30, 2016 | -2.514 |
| June 30, 2016 | -0.038 |
| March 31, 2016 | -0.1473 |
| December 31, 2015 | 0.16 |
| September 30, 2015 | 0.4913 |
| June 30, 2015 | -0.0267 |
| March 31, 2015 | -0.0918 |
| December 31, 2014 | 0.0017 |
| September 30, 2014 | 0.2225 |
| June 30, 2014 | 0.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 0.3557 |
| Pfizer Inc. | 0.5637 |
| Liquidia Corp. | -2.640 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 12.31M |
| Revenue (Quarterly) | 862.68M |
| Total Expenses (Quarterly) | 884.38M |
| Enterprise Value | 10.78B |
| Gross Profit Margin (Quarterly) | 38.73% |
| Profit Margin (Quarterly) | 1.43% |
| Earnings Yield | 1.91% |
| Operating Earnings Yield | 7.45% |
| Normalized Earnings Yield | 2.542 |